Asker acquires Health Net Connections

Bactiguard Holding has announced an update to its long standing collaboration with license partner BD (Becton, Dickinson & Company) through the signing of a restated long-term agreement.

When Encare was awarded the Swecare Export Award 2026, the company was highlighted as one of the Swedish healthtech companies that has succeeded in translating clinical research into concrete benefits in healthcare internationally.

Under the terms of the Transaction, Chiesi will commence a tender offer to acquire all outstanding shares of KalVista for USD 27.00 per share in cash. The total value implied by the transaction at closing is approximately USD 1.9 billion.

Belgian company UCB has announced signing of a definitive agreement under which it would acquire Candid Therapeutics, a privately held clinical-stage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through novel T-cell engagers (TCEs).

Gradientech has received a Notice of Allowance in the United States for its single-use microfluidic test, a key component of the CE marked QuickMIC system.

AddLife has acquired CoaChrom Diagnostica, an Austrian niche company specializing in advanced coagulation diagnostics.

Saga Diagnostics has entered into an agreement to be acquired by Foundation Medicine, an independent subsidiary of Roche, for a deal value of up to USD 595 million, including commercial and regulatory milestone payments.